LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.25 | 84.90 | 4133 | 4539 | 0.9104 | 0.9676 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.25 | 84.90 | 198 | 4539 | 0.0436 | 0.1590 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.25 | 84.90 | 4452 | 4539 | 0.9807 | 0.9932 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.95 | 84.90 | 4397 | 4952 | 0.8878 | 0.9598 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.95 | 84.90 | 4435 | 4952 | 0.8955 | 0.9627 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.95 | 84.90 | 4951 | 4952 | 0.9997 | 0.9999 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.95 | 84.90 | 4997 | 4952 | 1.0090 | 1.0030 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.95 | 84.90 | 421 | 4952 | 0.0850 | 0.3138 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.95 | 84.90 | 4548 | 4952 | 0.9183 | 0.9712 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.95 | 84.90 | 253 | 4952 | 0.0511 | 0.2046 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 46.95 | 84.90 | 4819 | 4952 | 0.9730 | 0.9907 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.65 | 84.90 | 4749 | 5328 | 0.8912 | 0.9618 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.65 | 84.90 | 4793 | 5328 | 0.8995 | 0.9648 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.65 | 84.90 | 5235 | 5328 | 0.9824 | 0.9941 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.65 | 84.90 | 5285 | 5328 | 0.9918 | 0.9972 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.65 | 84.90 | 411 | 5328 | 0.0771 | 0.3023 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.65 | 84.90 | 4882 | 5328 | 0.9162 | 0.9709 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.65 | 84.90 | 258 | 5328 | 0.0484 | 0.2046 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 48.65 | 84.90 | 5149 | 5328 | 0.9663 | 0.9885 | MN20160318_Q02 | H15 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.36 | 84.90 | 5089 | 5651 | 0.9005 | 0.9657 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.36 | 84.90 | 5122 | 5651 | 0.9064 | 0.9678 | MN20160318_Q02 | D03 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.36 | 84.90 | 5539 | 5651 | 0.9802 | 0.9934 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.36 | 84.90 | 5617 | 5651 | 0.9940 | 0.9980 | MN20160318_Q02 | D05 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.36 | 84.90 | 503 | 5651 | 0.0890 | 0.3415 | MN20160318_Q02 | G14 |
MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 50.36 | 84.90 | 5138 | 5651 | 0.9092 | 0.9688 | MN20160318_Q02 | G14 |